|
|
Volumn 135, Issue 8, 1999, Pages 981-982
|
|
Tetracycline and epidermolysis bullosa simplex: A new indication for one of the oldest and most widely used drugs in dermatology
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA TOCOPHEROL;
ALUMINUM CHLORIDE;
ANTIBIOTIC AGENT;
ANTIMALARIAL AGENT;
BUFEXAMAC;
CORTICOSTEROID;
CYCLOSPORIN;
CYPROHEPTADINE;
IMMUNOSUPPRESSIVE AGENT;
MINOCYCLINE;
PHENYTOIN;
PSORALEN;
RETINOID;
TETRACYCLINE;
ANTIINFLAMMATORY ACTIVITY;
CASE REPORT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG COST;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
EPIDERMOLYSIS BULLOSA;
HUMAN;
MALE;
MULTICENTER STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TOOTH COLOR;
TOPICAL DRUG ADMINISTRATION;
ANTI-BACTERIAL AGENTS;
EPIDERMOLYSIS BULLOSA SIMPLEX;
HUMANS;
TETRACYCLINE;
|
|
EID: 0032775620
PISSN: 0003987X
EISSN: None
Source Type: Journal
DOI: 10.1001/archderm.135.8.981 Document Type: Editorial |
|
Times cited : (11)
|
|
References (29)
|
